PHY1803: Clinical Outcomes of MICROPURE and PodEye Monofocal Intraocular Lenses

Sponsor
Beaver-Visitec International, Inc. (Industry)
Overall Status
Completed
CT.gov ID
NCT03796624
Collaborator
(none)
76
1
2
28.1
2.7

Study Details

Study Description

Brief Summary

Prospective, non-randomised, open, controlled, single-center post-market clinical follow study about Micropure 1.2.3. and PODEYE intraocular lenses.

Condition or Disease Intervention/Treatment Phase
  • Device: Micropure 1.2.3.
  • Device: PODEYE
N/A

Detailed Description

This clinical investigation is a prospective, non-randomised, open, controlled, single-center post-market clinical follow whereby study patients undergoing routine cataract surgery will have implantation of monofocal intraocular lens Micropure 1.2.3. (PhysIOL, Liège, Belgium) in one eye and implantation of monofocal intraocular lens PODEYE (PhysIOL, Liège, Belgium) in the contralateral eye of the same patient.

The study purpose is to obtain clinical data on visual acuity and contrast sensitivity on patients implanted with Micropure 1.2.3. and PODEYE

The devices under investigation (Micropure 1.2.3. and PODEYE) are a monofocal glistening-free hydrophobic acrylic intraocular lenses (IOLs) manufactured by the sponsor of this study PhysIOL sa/nv. The optical properties of the lenses are very comparable. The main difference is the mechanical design of the haptics, that is not expected to have an influence on the clinical outcomes.

The IOLs will be implanted as part of the routine cataract surgery on patients suffering from cataract development.

In total 76 patients will be recruited for this clinical study and receive the implantation of Micropure 1.2.3. and POPDEYE intraocular lenses.

Subjects participating in the trial will attend study visits over a period of 12 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
76 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Clinical Outcomes After Implantation of MICROPURE (PhysIOL) and PodEye (PhysIOL) Monofocal Intraocular Lenses Into the Two Eyes of the Same Patient
Actual Study Start Date :
Feb 12, 2019
Actual Primary Completion Date :
Jun 17, 2021
Actual Study Completion Date :
Jun 17, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Investigational Device Micropure 1.2.3.

Implantation of monofocal intraocular lens (IOL) "Micropure 1.2.3." in one of the eyes of the study subject

Device: Micropure 1.2.3.
Implantation of intraocular lens (IOL). Name: "MicroPure 1.2.3." It is a monofocal intraocular lens consisting of hydrophobic acrylic material. One IOL per patient will be implanted

Active Comparator: Comparator PODEYE

Implantation of monofocal intraocular lens (IOL) "PODEYE" in the contralateral eye of the study subject

Device: PODEYE
Implantation of intraocular lens (IOL). Name: "PODEYE" It is a monofocal intraocular lens consisting of hydrophobic acrylic material. The IOL will be implanted in the contralateral eye of the same patient already implanted with Micropure 1.2.3.

Outcome Measures

Primary Outcome Measures

  1. monocular Corrected Distance Visual Acuity (CDVA) [6 months postoperative]

    Statistically non-inferior visual acuity outcomes on monocular Corrected Distance Visual Acuity (CDVA) under photopic light conditions compared to eyes implanted with the comparator PODEYE at the 6 months follow up visit.

Secondary Outcome Measures

  1. Manifested refraction [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The manifested refraction is measured by means of a phoropter. The data contains values for sphere, cylinder and axis of cylinder according to ISO 11979-7:2018.

  2. Monocular Uncorrected Distance Visual Acuity (UDVA) under photopic light conditions [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    UDVA is measured with ETDRS charts placed in 4m distance according to ISO 11979-7:2018. This assessment is performed under photopic light conditions

  3. Monocular Uncorrected Distance Visual Acuity (UDVA) under mesopic light conditions [preoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    UDVA is measured with ETDRS charts placed in 4m distance according to ISO 11979-7:2018. This assessment is performed under mesopic light conditions

  4. Monocular Corrected Distance Visual Acuity (CDVA) under photopic light conditions [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    CDVA is measured with ETDRS charts placed in 4m distance with best aided corrective glasses according to ISO 11979-7:2018. This assessment is performed under photopic light conditions

  5. Monocular Corrected Distance Visual Acuity (CDVA) under mesopic light conditions [preoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    CDVA is measured with ETDRS charts placed in 4m distance with best aided corrective glasses according to ISO 11979-7:2018. This assessment is performed under mesopic light conditions

  6. Monocular Contrast Sensitivity under photopic light conditions [6 months postoperative]

    Contrast Sensitivity under photopic light conditions using the standardized contrast sensitivity device CSV-1000 (VectorVision)

  7. Monocular Contrast Sensitivity under mesopic light conditions [6 months postoperative]

    Contrast Sensitivity under mesopic light conditions using the standardized contrast sensitivity device CSV-1000 (VectorVision)

  8. Slitlamp examination - Corneal status [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Corneal status.

  9. Slitlamp examination - Fundus [preoperative, 12 months postoperative]

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Fundus.

  10. Slitlamp examination - Signs of inflammation [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Signs of inflammation.

  11. Slitlamp examination - Pupillary block [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Pupillary block.

  12. Slitlamp examination - Retinal detachment [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Retinal detachment.

  13. Slitlamp examination - Status of anterior and posterior capsule [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • Status of anterior and posterior capsule.

  14. Slitlamp examination - IOL decentration [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • IOL decentration.

  15. Slitlamp examination IOL tilt [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • IOL tilt.

  16. Slitlamp examination - IOL discoloration [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • IOL discoloration.

  17. Slitlamp examination - IOL opacity [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The slitlamp examination is one examination to analyse the integrity of eye structures and the implanted IOL. The examination is performed and documented according to the guidelines in ISO 11979-7:2018. With the slitlamp the ophthalmologist can observe the eyes stereoscopically. A focussed slit of light, which can be width-adjusted, is projected on the eye to be examined. The investigator observes this projection on the eye through a reflected light microscope. The slitlamp is used to observe the anterior and posterior part of the eye, including cornea, lens and anterior chamber. By dilating the pupil the fundus can also be examined. Following conditions shall be examined with the slitlamp: • IOL opacity.

Other Outcome Measures

  1. Intraocular pressure (IOP) measurement [preoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative, 12 months postoperative]

    The IOP will be measured with non-contact tonometer as part of the routine follow up examinations

  2. Questionnaire on IOL implantation [peroperative]

    A questionnaire will be handed out to the surgeon right after the surgery to document the ease of use and possible issues during IOL implantation. These data will be used to compare the outcomes to different surgery techniques or injectors. The questionnaire is not validated and the outcomes serve only for the sponsor to receive feedback if one or the other IOL is easier to implant.

  3. Keratometry [preoperative]

    Keratometric measurements are performed to calculate the required IOL power

  4. Biometry [preoperative]

    Biometry measurements are performed to calculate the required IOL power

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Cataractous eyes with no comorbidity

  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures

  • Clear intraocular media other than cataract;

  • Signed informed consent

Exclusion Criteria:
  • Age of patient < 45 years;

  • Irregular astigmatism;

  • Regular corneal astigmatism >0.75 dioptres by an automatic keratometer or biometer or

1.0 dioptres if the steep axis of cylinder is between 90° and 120°;

  • Difficulty for cooperation (distance from their home, general health condition);

  • Previous intraocular or corneal surgery;

  • Traumatic cataract;

  • Any ocular comorbidity;

  • Instability of keratometry or biometry measurements.

Contacts and Locations

Locations

Site City State Country Postal Code
1 GEMINI Eye Clinic Zlin Czechia 76001

Sponsors and Collaborators

  • Beaver-Visitec International, Inc.

Investigators

  • Principal Investigator: Pavel Stodůlka, MD, PhD, Gemini Eye Clinic

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Beaver-Visitec International, Inc.
ClinicalTrials.gov Identifier:
NCT03796624
Other Study ID Numbers:
  • PHY1803
First Posted:
Jan 8, 2019
Last Update Posted:
Jul 9, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Beaver-Visitec International, Inc.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 9, 2021